Protocol IK-4001-HRS-301: A MultiCenter, Randomized, Placebo Controlled, Double Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1, with Lucassin (Terlipressin)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/14/109/14/13

Funding

  • Ikaria Therapeutics, LLC (IK-4001-HRS-301)